Wyrick Susan D. 4
4 · Sana Biotechnology, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Wyrick Susan D.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2026-01-02+7,500→ 188,290 total - Tax Payment
Common Stock
2026-01-05$4.27/sh−2,407$10,278→ 185,883 total - Exercise/Conversion
Restricted Stock Units
2026-01-02−7,500→ 0 total→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. common stock.
- [F2]The award vested as to 40% of the restricted stock units on January 2, 2025 and 60% of the restricted stock units on January 2, 2026.